Prevention of Heart and Blood Vessel Disease in Women with Lupus
Women with lupus have a five-to ten-fold increased risk of cardiovascular disease compared to women in the general population. The LFA has Awarded to research grants to address this serious manifestation of lupus. Funding has been provided to:
Betty P. Tsao, Ph.D., University of California, Los Angeles, Effects of Statin an ApoA-1 Mimetic Peptide in a Mouse Model of Heart Disease in Lupus.
James C. Oates, M.D., Medical University of South Carolina, Biomarkers of Reactive Nitrogen and Oxygen Stress as Risk Factors for Cardiovascular Disease in African Americans with Lupus
Lupus Foundation of America Provides $1Million to Support Lupus Research
The Lupus Foundation of America Board of Directors, through its Five-Year Research Program, Bringing Down the Barriers, has this year awarded research grants to 23 investigators at 22 institutions in the United States, adding nearly $1million to LFA’s on-going commitment to lupus research. Since its inception, the LFA and its chapters have provided more than $16 million to support lupus research.
Georgia Lupus Registry
Each of the registries represents a different geographic area and contains large number of people at risk for lupus. The Georgia registry is led by the division of Rheumatology at Emory University in partnership with the Georgia Department of Human Resources (DHR).
The Georgia Lupus Registry (GLR) aims to develop, implement, and support a population based disease registry to determine the prevalence and incidence of systemic lupus within Fulton, DeKalb, and Richmond (Augusta) counties. Acting as public health agents under the auspices of GA DHR, the registry will identify as many hospitals and practitioners as possible who are providing care to potential lupus patients. These are rheumatologists, nephrologists, dermatologists, obstetricians, cardiologists, neurologists, and hematologists, as well as internists and primary care physicians. The LFA Georgia chapter helps identify patients and their healthcare providers.
The results of the Georgia Lupus Registry and biomarker research funded by the Department of Defense could help accelerate the introduction of new therapies and treatment of lupus patients. There has not been a new FDA approved drug for lupus for over 40 years.
Sam Lim MD, MPH, Assistant Professor Medicine at Emory and chair of the LFA Georgia Chapter's Medical Advisory Board